Gossypol induces apoptosis in ovarian cancer cells through oxidative stress

Molecular BioSystems

Volumn 9, Issue 6, 2013, Pages 1489-1497

  Wang, Jia ^a   Jin, Lixu ^a   Li, Xiaoyu ^b   Deng, Haiyun ^a   Chen, Yuling ^c   Lian, Qingquan ^a   Ge, Renshan ^a   Deng, Haiteng ^c  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CARRIER PROTEIN; CHAPERONIN 60; DISULFIDE; FLAVINE ADENINE NUCLEOTIDE; GLUTATHIONE; GOSSYPOL; HSPD1 PROTEIN, HUMAN; MALE CONTRACEPTIVE AGENT; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; PROTEOME; THIOL DERIVATIVE; THYROID HORMONE; THYROID HORMONE-BINDING PROTEINS; THYROID HORMONE BINDING PROTEINS;

APOPTOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; METABOLISM; METABOLOMICS; OVARIAN NEOPLASMS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; PROTEOMICS; TUMOR CELL LINE; ARTICLE; OVARY TUMOR;

APOPTOSIS; ASPARTIC ACID; CARRIER PROTEINS; CELL LINE, TUMOR; CHAPERONIN 60; CONTRACEPTIVE AGENTS, MALE; DISULFIDES; FEMALE; FLAVIN-ADENINE DINUCLEOTIDE; GENE EXPRESSION PROFILING; GLUTATHIONE; GOSSYPOL; HUMANS; MEMBRANE PROTEINS; METABOLOMICS; MITOCHONDRIAL PROTEINS; OVARIAN NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEOME; PROTEOMICS; SULFHYDRYL COMPOUNDS; THYROID HORMONES;

EID: 84877730312     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c3mb25461e     Document Type: Article

References (51)

1. D. Bell A. Berchuck M. Birrer J. Chien D. Cramer F. Dao et al., Integrated genomic analyses of ovarian carcinoma Nature 2011 474 609 615
2. D. S. Miller J. A. Blessing C. N. Krasner R. S. Mannel P. Hanjani M. L. Pearl et al., Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group J. Clin. Oncol. 2009 27 2686 2691
3. A. Jemal R. Siegel E. Ward Y. Hao J. Xu M. J. Thun Cancer statistics Ca-Cancer J. Clin. 2009 59 225 249
4. A. A. Ahmed D. Etemadmoghadam J. Temple A. G. Lynch M. Riad R. Sharma et al., Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary J. Pathol. 2010 221 49 56
5. F. Tas D. Duranyildiz H. Oguz H. Camlica V. Yasasever E. Topuz The value of serum bcl-2 levels in advanced epithelial ovarian cancer Med. Oncol. 2006 23 213 217
6. N. S. Anderson L. Turner S. Livingston R. Chen S. V. Nicosia P. A. Kruk Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation J. Ovarian Res. 2009 2 16
7. A. M. Petros A. Medek D. G. Nettesheim D. H. Kim H. S. Yoon K. Swift et al., Solution structure of the antiapoptotic protein bcl-2 Proc. Natl. Acad. Sci. U. S. A. 2001 98 3012 3017
8. M. Sattler H. Liang D. Nettesheim R. P. Meadows J. E. Harlan M. Eberstadt et al., Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis Science 1997 275 983 986
9. A. M. Petros D. G. Nettesheim Y. Wang E. T. Olejniczak R. P. Meadows J. Mack et al., Rationale for Bcl-XL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies Protein Sci. 2000 9 2528 2534
10. J. L. Wang D. Liu Z. J. Zhang S. Shan X. Han S. M. Srinivasula et al., Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells Proc. Natl. Acad. Sci. U. S. A. 2000 97 7124 7129
11. A. Degterev A. Lugovskoy M. Cardone B. Mulley G. Wagner T. Mitchison et al., Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL Nat. Cell Biol. 2001 3 173 182
12. S. P. Tzung K. M. Kim G. Basañez C. D. Giedt J. Simon J. Zimmerberg et al., Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3 Nat. Cell Biol. 2001 3 183 191
13. G. Wang Z. Nikolovska-Coleska C. Y. Yang R. Wang G. Tang J. Guo et al., Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins J. Med. Chem. 2006 49 6139 6142
14. C. L. Oliver M. B. Miranda S. Shangary S. Land S. Wang D. E. Johnson (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2-and Bcl-XL-mediated apoptosis resistance Mol. Cancer Ther. 2005 4 23 31
15. V. Voss C. Senft V. Lang M. W. Ronellenfitsch J. P. Steinbach V. Seifert et al., The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma Mol. Cancer Res. 2010 8 1002 1016
16. J. Lian X. Wu F. He D. Karnak W. Tang Y. Meng et al., A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum Cell Death Differ. 2010 18 60 71
17. Y. Meng W. Tang Y. Dai X. Wu M. Liu Q. Ji et al., Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa Mol. Cancer Ther. 2008 7 2192 2202
18. R. C. Stein A. Joseph S. A. Matlin D. C. Cunningham H. T. Ford R. C. Coombes A preliminary clinical study of gossypol in advanced human cancer Cancer Chemother. Pharmacol. 1992 30 480 482
19. Y. Yu J. A. Deck L. A. Hunsaker L. M. Deck R. E. Royer E. Goldberg et al., Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C41 Biochem. Pharmacol. 2001 62 81 89
20. H. Cheong C. Lu T. Lindsten C. B. Thompson Therapeutic targets in cancer cell metabolism and autophagy Nat. Biotechnol. 2012 30 671 678
21. A. Le C. R. Cooper A. M. Gouw R. Dinavahi A. Maitra L. M. Deck et al., Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression Proc. Natl. Acad. Sci. U. S. A. 2010 107 2037 2042
22. J. Jiang W. Ye Y. C. Lin Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling Int. J. Mol. Med. 2009 24 69 75
23. S. R. Volate B. T. Kawasaki E. M. Hurt J. A. Milner Y. S. Kim J. White et al., Gossypol Induces Apoptosis by Activating p53 in Prostate Cancer Cells and Prostate Tumor-Initiating Cells Mol. Cancer Ther. 2010 9 461 470
24. S. F. Zerp R. Stoter G. Kuipers D. Yang M. E. Lippman W. J. Van Blitterswijk et al., AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis Radiat. Oncol. 2009 4 1 10
25. Z. Y. Hu J. Sun X. F. Zhu D. Yang Y. X. Zeng ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway J. Transl. Med. 2009 7 74
26. D. O. Moon M. O. Kim J. D. Lee G. Y. Kim Gossypol suppresses NF-kappaB activity and NF-kappaB-related gene expression in human leukemia U937 cells Cancer Lett. 2008 264 192 200
27. X. Pang Y. Wu B. Lu J. Chen J. Wang Z. Yi et al., (-)-Gossypol Suppresses the Growth of Human Prostate Cancer Xenografts via Modulating VEGF Signaling-Mediated Angiogenesis Mol. Cancer Ther. 2011 10 795 805
28. U. Varol B. Karaca D. Tunali M. Degirmenci Y. Cirak D. Purcu et al., The effect of racemic gossypol and at-101 on angiogenic profile of ovcar-3 cells: a preliminary molecular framework for gossypol enantiomers Exp. Oncol. 2009 31 220 225
29. C. H. Ko S. C. Shen L. Y. Yang C. W. Lin Y. C. Chen Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells Int. J. Cancer 2007 121 1670 1679
30. B. Sung J. Ravindran S. Prasad M. K. Pandey B. B. Aggarwal Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to trail J. Biol. Chem. 2010 285 35418 35427
31. M. J. Sikora J. A. Bauer M. Verhaegen T. J. Belbin M. B. Prystowsky J. C. Taylor et al., Anti-oxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol Cancer Biol. Ther. 2008 7 769 778
32. D. Trachootham J. Alexandre P. Huang Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discovery 2009 8 579 591
33. H. Pelicano D. Carney P. Huang ROS stress in cancer cells and therapeutic implications Drug Resist. Updates 2004 7 97 110
34. J. Chandra Oxidative stress by targeted agents promotes cytotoxicity in hematologic malignancies Antioxid. Redox Signaling 2009 11 1123 1137
35. S. E. Leonard K. S. Carroll Chemical 'omics' approaches for understanding protein cysteine oxidation in biology Curr. Opin. Chem. Biol. 2011 15 88 102
36. N. Brandes D. Reichmann H. Tienson L. I. Leichert U. Jakob Using quantitative redox proteomics to dissect the yeast redoxome J. Biol. Chem. 2011 286 41893 41903
37. L. I. Leichert F. Gehrke H. V. Gudiseva T. Blackwell M. Ilbert A. K. Walker et al., Quantifying changes in the thiol redox proteome upon oxidative stress in vivo Proc. Natl. Acad. Sci. U. S. A. 2008 105 8197 8202
38. K. G. Victor J. M. Rady J. V. Cross D. J. Templeton Proteomic Profile of Reversible Protein Oxidation Using PROP, Purification of Reversibly Oxidized Proteins PLoS One 2012 7 e32527
39. M. Lindahl A. Mata-Cabana T. Kieselbach The disulfide proteome and other reactive cysteine proteomes: analysis and functional significance Antioxid. Redox Signaling 2011 14 2581 2642
40. H. Morimoto S. Yonehara B. Bonavida Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins Cancer Res. 1993 53 2591 2596
41. H. Morimoto J. T. Safrit B. Bonavida Synergistic effect of tumor necrosis factor-alpha-and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines J. Immunol. 1991 147 2609 2616
42. R. Franco J. A. Cidlowski Glutathione efflux and cell death Antioxid. Redox Signaling 2012 17 1694 1713
43. Y. Higuchi Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis J. Cell. Mol. Med. 2004 8 455 464
44. A. L. Ortega S. Mena J. M. Estrela Glutathione in cancer cell death Cancers 2011 3 1285 1310
45. Y. Hamnell-Pamment C. Lind C. Palmberg T. Bergman I. A. Cotgreave Determination of site-specificity of S-glutathionylated cellular proteins Biochem. Biophys. Res. Commun. 2005 332 362 369
46. Y. Nagumo H. Kakeya M. Shoji Y. Hayashi N. Dohmae H. Osada Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity Biochem. J. 2005 387 835 840
47. D. Anastasiou G. Poulogiannis J. M. Asara M. B. Boxer J. Jiang M. Shen et al., Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses Sci. Signaling 2011 334 1278 1283
48. R. B. Hamanaka N. S. Chandel Warburg effect and redox balance Sci. Signaling 2011 334 1219 1220
49. M. Gutscher M. C. Sobotta G. H. Wabnitz S. Ballikaya A. J. Meyer Y. Samstag et al., Proximity-based protein thiol oxidation by H2O 2-scavenging peroxidases J. Biol. Chem. 2009 284 31532 31540
50. C. S. Velu S. K. Niture C. E. Doneanu N. Pattabiraman K. S. Srivenugopal Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress Biochemistry 2007 46 7765 7780
51. J. Scotcher D. Clarke L. Mackay T. Hupp P. J. Sadler P. Langridge-Smith Redox Regulation of Tumour Suppressor Protein p53: Identification of the Sites of Hydrogen Peroxide Oxidation and Glutathionylation Chem. Sci. 2013 4 1257 1269